Written Question·Department of Health and Social Care·UIN 83208
Abiraterone
Tabled: 17 October 2025
Answered: 28 October 2025
Question
Danny Beales
Labour — Uxbridge and South Ruislip
To ask the Secretary of State for Health and Social Care, what information his Department holds on the estimate made by (a) NHS England, (b) NHS Wales and (c) NHS Scotland of the incremental cost-effectiveness ratio for abiraterone in high-risk, non-metas
Answer
Dr Zubir AhmedNHS England has not calculated the incremental cost-effectiveness ratio for any policy proposition because NHS England uses a relative prioritisation process for policy propositions that require funding in line with the published NHS England Specialised C...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 83208) →